Enteral Nutrition Clinical Trial
Official title:
Effects of Enteral Nutrition on Stress Ulcer Hemorrage. Multicenter Randomized Controlled
Enteral nutrition can provides prophylaxis against stress ulcer bleeding in critically ill patients and there may be no need to use acid suppressing drugs for stress ulcer bleeding prophylaxis in these patients. Half of the patients on enteral nutrition will not receive any acid suppressing drugs while other half receives it. They will be followed for gastrointestinal bleeding.
Mucosal erosions can occur on luminal surface of stomach in approximately 75-100% patients
during the first 24 hours of intensive care unit admission. These erosions often cause
bleeding with penetrating superficial capillaries. Clinically significant bleeding
(Significant decrease in blood pressure or decrease in hemoglobin level of more than 2 g /
dL) appears to be less than 5% in ICU patients.
Enteral nutrition (EN) has protective effects against stress ulcer bleeding by neutralizing
the acidic pH in the stomach lumen, providing a structural and functional integrity of the
mucosal surface and trophic effect on the GI mucosa. These effects have been shown in some
studies. The above-mentioned studies are inadequate for clinicians to make suggestions for
relation between enteral nutrition and stress ulcer hemorrhage.
The risk factors for stress ulcer hemorrhage are mechanical ventilation, coagulopathy and
burns.
Proton pump inhibitors (PPI) and histamine receptor blockers (H2RB) are the main drugs used
for stress ulcer bleeding prophylaxis.
Studies have shown that 90% of patients admitted to intensive care units receive prophylaxis
for stress ulcer bleeding.
Drugs (H2RB, PPI) used for prophylaxis against stress ulcer bleeding have some undesirable
harmful effects in critical illnesses. These drugs, which suppress gastric acid secretion,
can cause hospital-associated pneumonia and Clostridium difficile enterocolitis.
The studies, for clinical proposals are generally performed in the 1980s and early 1990s.
Oral intake was stopped in most of the critically ill patients and early enteral nutrition
was not widely used at the time of these major studies performed. Patients who are receiving
EN have been shown to develop less stress ulcer bleeding in some studies. In a limited
number of animal studies, enteral feeding has been shown to protect stress-related mucosal
damage in the gastric mucosa.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02913677 -
Prolonged Minimal Enteral Nutrition Versus Slowly Advancing Enteral Nutrition in Very Low Birth Weight Infants:
|
N/A | |
Not yet recruiting |
NCT00916591 -
Prokinetic Drugs and Enteral Nutrition
|
N/A | |
Completed |
NCT01025167 -
The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients
|
N/A | |
Not yet recruiting |
NCT05900323 -
Enteral Nutrition Guidelines and Patients' Outcomes
|
N/A | |
Completed |
NCT03153397 -
Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)
|
N/A | |
Completed |
NCT02353689 -
The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement
|
Phase 2/Phase 3 | |
Terminated |
NCT00564655 -
Regional Anesthesia Block of the Transversus Abdominis Plane in Children Undergoing Gastric Tube Insertion
|
Phase 3 | |
Completed |
NCT06134674 -
Early Versus Delayed Enteral Nutrition in Critically Ill Adults With COVID-19
|
||
Recruiting |
NCT03791866 -
The Th9/IL-9 and Early Enteral Nutrition in Sepsis
|
N/A | |
Enrolling by invitation |
NCT06161350 -
The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
|
||
Active, not recruiting |
NCT02724631 -
TubeClear® Evaluation in Pediatric Patients (Phase I)
|
N/A | |
Completed |
NCT01988792 -
Human Milk Fortification in Very Low Birth Neonates
|
N/A | |
Completed |
NCT00600678 -
Gastric Emptying Study After Administration of a High Caloric Sip Feed
|
N/A | |
Completed |
NCT02998931 -
Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients
|
Phase 3 | |
Not yet recruiting |
NCT06411873 -
The Effect of High Protein Enteral Nutrition on Critically Ill Postoperative Children
|
N/A | |
Recruiting |
NCT03176875 -
Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease
|
N/A | |
Completed |
NCT02779335 -
Enteral Formula Tolerance in Pediatric Patients
|
N/A | |
Completed |
NCT05411848 -
2kcal Tube Feed Study
|
N/A | |
Completed |
NCT04868318 -
The Impact of Intervention With High-protein Enteral Formula in SICU.
|
N/A | |
Withdrawn |
NCT04601571 -
Confirming Feeding Tube Position Using CORTRAK
|
N/A |